Status: Not yet recruiting
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas
The purpose of this study is to determine whether combining of Temozolomide and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with Advanced Malignant Gliomas. The effectiveness and safety of CIK cells for the treatment of Malignant Glioma is also evaluated.
Participants needed: 120
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: The First People's Hospital of ChangzhouUpdated: Jul 14, 2015
Eligibility criteria
Subjects with documented histologically confirmed primary grade 4 advanced malig... [+7]
Progressed while on temozolomide. [+8]